J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartley, M. G.
Right arrow Articles by Grace, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartley, M. G.
Right arrow Articles by Grace, R. H.
Agricola
Right arrow Articles by Hartley, M. G.
Right arrow Articles by Grace, R. H.

The Journal of Medical Microbiology, Vol 36, Issue 2 96-103, Copyright © 1992 by Society for General Microbiology


JOURNAL ARTICLE

The rectal mucosa-associated microflora in patients with ulcerative colitis

M. G. Hartley, M. J. Hudson, E. T. Swarbrick, M. J. Hill, A. E. Gent, M. D. Hellier and R. H. Grace
Pathology Division, PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury.

The rectal mucosa-associated flora (MAF) of patients with ulcerative colitis has been studied in 25 patients with newly diagnosed disease, 20 with relapse of existing disease, and 44 who were in remission. Patients with active disease were re-examined twice during treatment. The MAF was simpler and less dense than the microflora of faeces. Obligate anaerobes usually predominated in the MAF although the ratio of obligate anaerobes to facultative species was lower than that found in faeces. Viable counts of the total flora and of its constituent genera varied considerably between patients. Counts of the total flora, of obligate anaerobes (including bifidobacteria, eubacteria and clostridia), and facultative organisms and micro-aerobes (enterobacteria and lactobacilli) were reduced in patients with active disease compared with those with inactive disease; corresponding carriage rates were also lower. Counts and carriage rates increased during treatment and approached those found in quiescent disease. The alterations in the MAF were especially marked in patients experiencing their first attack of ulcerative colitis. The relationship between these alterations and the aetiology and pathogenesis of this disease remains unclear.


This article has been cited by other articles:


Home page
Int. J. Syst. Evol. Microbiol.Home page
A. R. Cook, P. W. Riley, H. Murdoch, P. N. Evans, and I. R. McDonald
Howardella ureilytica gen. nov., sp. nov., a Gram-positive, coccoid-shaped bacterium from a sheep rumen
Int J Syst Evol Microbiol, December 1, 2007; 57(12): 2940 - 2945.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M P Conte, S Schippa, I Zamboni, M Penta, F Chiarini, L Seganti, J Osborn, P Falconieri, O Borrelli, and S Cucchiara
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease
Gut, December 1, 2006; 55(12): 1760 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
K. Lucke, S. Miehlke, E. Jacobs, and M. Schuppler
Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis.
J. Med. Microbiol., May 1, 2006; 55(Pt 5): 617 - 624.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E Furrie, S Macfarlane, A Kennedy, J H Cummings, S V Walsh, D A O'Neil, and G T Macfarlane
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial
Gut, February 1, 2005; 54(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E Furrie, S Macfarlane, J H Cummings, and G T Macfarlane
Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response
Gut, January 1, 2004; 53(1): 91 - 98.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. C. Ouwehand, S. Salminen, P. J. Roberts, J. Ovaska, and E. Salminen
Disease-Dependent Adhesion of Lactic Acid Bacteria to the Human Intestinal Mucosa
Clin. Vaccine Immunol., July 1, 2003; 10(4): 643 - 646.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
E. G. Zoetendal, A. von Wright, T. Vilpponen-Salmela, K. Ben-Amor, A. D. L. Akkermans, and W. M. de Vos
Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces
Appl. Envir. Microbiol., July 1, 2002; 68(7): 3401 - 3407.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Orrhage, S. Sjostedt, and C. E. Nord
Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil
J. Antimicrob. Chemother., October 1, 2000; 46(4): 603 - 612.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G Kolios, N Rooney, C T Murphy, D A F Robertson, and J Westwick
Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines
Gut, July 1, 1998; 43(1): 56 - 63.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1992 Society for General Microbiology.